MedTrace Logo

Conventional Antibiotic Prophylaxis Versus Add-On 5 Days Levofloxacin Before Percutaneous Nephrolithotomy

NCT03178292 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-06-06

No results posted yet for this study

Summary

To evaluate whether 5 days of levofloxacin before percutaneous nephrolithotomy (PCNL) in reducing upper urinary tract infection and urosepsis after PCNL.

Conditions

Interventions

DRUG

Levofloxacin

Levofloxacin 500Mg daily for 5 days

DRUG

Placebo

Placebo Oral Tablet daily for 5 days

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ahmed Shoma, MD · Urology and Nephrology center

  • Nasr Eltabey, MD · Urology and Nephrology center

  • Mahmoud Laimon, Msc · Urology and Nephrology center

  • Muhamad Abdullateef, Msc · Urology and Nephrology center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2017-06-15
Completion
2017-06-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03178292 on ClinicalTrials.gov